{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:28:16Z","timestamp":1792510096899,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":96,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R37 CA225655"],"award-info":[{"award-number":["R37 CA225655"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1038\/s41379-022-01100-z","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T07:02:50Z","timestamp":1658559770000},"page":"1484-1493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities?"],"prefix":"10.1016","volume":"35","author":[{"given":"Valerie A.","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin D.","family":"Hyrcza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2434-4978","authenticated-orcid":false,"given":"Jochen K.","family":"Lennerz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Thierauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilani","family":"Lokuhetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5007-9456","authenticated-orcid":false,"given":"Ian A.","family":"Cree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0259-4781","authenticated-orcid":false,"given":"Blanca Iciar","family":"Indave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-022-01100-z_bib1","unstructured":"World Health Organization Classification of Tumours Editorial Board, BlueBooksOnline - WHO Classification of Tumours Online, https:\/\/tumourclassification.iarc.who.int\/aboutus (2021)."},{"key":"10.1038\/s41379-022-01100-z_bib2","doi-asserted-by":"crossref","unstructured":"Cree, I. A., Indave Ruiz, B. I., Zavidil J., McKay J., Olivier M., Kozlakidis Z., et al. The International Collaboration for Cancer Classification and Research. Int. J. Cancer148, 560-571 (2021).","DOI":"10.1002\/ijc.33260"},{"key":"10.1038\/s41379-022-01100-z_bib3","doi-asserted-by":"crossref","unstructured":"Hoadley, K. A., Yau, C., Wolf, D. M., Cherniack, A. D., Tamborero D., Ng, S., et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell158, 929944 (2014).","DOI":"10.1016\/j.cell.2014.06.049"},{"key":"10.1038\/s41379-022-01100-z_bib4","doi-asserted-by":"crossref","unstructured":"Uttley, L., Indave, B.I., Hyde, C., White, V., Lokuhetty, D. & Cree, I. Invited commentary-WHO Classification of Tumours: How should tumors be classified? Expert consensus, systematic reviews or both? Int. J. Cancer146, 3516-3521 (2020).","DOI":"10.1002\/ijc.32975"},{"key":"10.1038\/s41379-022-01100-z_bib5","doi-asserted-by":"crossref","unstructured":"Diaz-Cano, S. J. Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design. Int. J. Mol. Sci. 13, 1951-2011 (2012).","DOI":"10.3390\/ijms13021951"},{"key":"10.1038\/s41379-022-01100-z_bib6","doi-asserted-by":"crossref","unstructured":"Colomer, R., Mondejar, R., Romero-Laorden, N., Alfranca, A., Sanchez-Madrid, F. & Quintela-Fandino, M. When should we order a next generation sequencing test in a patient with cancer? eClinicalMedicine25, 100487 (2020).","DOI":"10.1016\/j.eclinm.2020.100487"},{"key":"10.1038\/s41379-022-01100-z_bib7","doi-asserted-by":"crossref","unstructured":"Nemtsova, M. V., Kalinkin, A. I., Kuznetsova, E. B., Bure, I. V., Alekseeva, E. A., Khorobrykh, T. V., et al. Clinical relevance of somatic mutations in main driver genes detected in gastric cancer patients by next-generation DNA sequencing. Sci. Rep. 10, 504 (2020).","DOI":"10.1038\/s41598-020-57544-3"},{"key":"10.1038\/s41379-022-01100-z_bib8","doi-asserted-by":"crossref","unstructured":"Altman, N. & Krzywinski, M. Association, correlation and causation. Nat. Methods12, 899-900 (2015).","DOI":"10.1038\/nmeth.3587"},{"key":"10.1038\/s41379-022-01100-z_bib9","doi-asserted-by":"crossref","unstructured":"Schober, P., Boer, C. & Schwarte, L. A. Correlation Coefficients: Appropriate Use and Interpretation. Anesth. Analg.126, 1763-1768 (2018).","DOI":"10.1213\/ANE.0000000000002864"},{"key":"10.1038\/s41379-022-01100-z_bib10","doi-asserted-by":"crossref","unstructured":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther.69, 89-95 (2001).","DOI":"10.1067\/mcp.2001.113989"},{"key":"10.1038\/s41379-022-01100-z_bib11","doi-asserted-by":"crossref","unstructured":"Strimbu, K. & Tavel, J. A. What are biomarkers? Curr. Opin. HIV AIDS5, 463466 (2010).","DOI":"10.1097\/COH.0b013e32833ed177"},{"key":"10.1038\/s41379-022-01100-z_bib12","unstructured":"World Health Organization Classification of Tumours Editorial Board, Thoracic tumours. 5th edn, Vol. 1 (IARC Publications: Lyon (France), 2019)."},{"key":"10.1038\/s41379-022-01100-z_bib13","doi-asserted-by":"crossref","unstructured":"Keelawat, S., Liu, C. Z., Roehm, P. C. & Barnes, L. Adenosquamous carcinoma of the upper aerodigestive tract: a clinicopathologic study of 12 cases and review of the literature. Am. J. Otolaryngol. 23, 160-168 (2002).","DOI":"10.1053\/ajot.2002.123462"},{"key":"10.1038\/s41379-022-01100-z_bib14","unstructured":"Jordan, E. J., Basturk, O., Leach, S.D., Klimstra, D.S., Allen, P.J., Berger, M.F., et al. Clinical and Molecular Analysis of Adenosquamous Carcinoma of the Pancreas. J. Pancreas17, 620-628 (2016)."},{"key":"10.1038\/s41379-022-01100-z_bib15","doi-asserted-by":"crossref","unstructured":"Alos, L., Castillo, M., Nadal, A., Caballero, M., Mallofre, C., Palacin, A., et al. Adenosquamous carcinoma of the head and neck: criteria for diagnosis in a study of 12 cases. Histopathology44, 570-579 (2004).","DOI":"10.1111\/j.1365-2559.2004.01881.x"},{"key":"10.1038\/s41379-022-01100-z_bib16","unstructured":"El-Naggar A.K., Chan, J. K. C., Grandis, J.R., Takata, T. & Slootweg, P.J. WHO Classification of Head and Neck Tumours. 4th edn, Vol. 1 (IARC Publications, 2019)."},{"key":"10.1038\/s41379-022-01100-z_bib17","doi-asserted-by":"crossref","unstructured":"Nordkvist, A., Gustafsson, H., Jubergode, M. & Stenman, G. Recurrent rearrangements of 11Q14-22 in Mucoepidermoid Carcinoma. Cancer Genet. 74, 77-83 (1994).","DOI":"10.1016\/0165-4608(94)90001-9"},{"key":"10.1038\/s41379-022-01100-z_bib18","doi-asserted-by":"crossref","unstructured":"Enlund, F., Behboudi, A., Andren, Y., Oberg, C., Lendahl, U., Mark, J., et al. Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors. Exp. Cell Res. 292, 21-28 (2004).","DOI":"10.1016\/j.yexcr.2003.09.007"},{"key":"10.1038\/s41379-022-01100-z_bib19","doi-asserted-by":"crossref","unstructured":"Bell, D. & El-Naggar, A. K. Molecular Heterogeneity in Mucoepidermoid Carcinoma: Conceptual and Practical Implications. Head and Neck Pathol. 7, 23-27 (2013).","DOI":"10.1007\/s12105-013-0432-5"},{"key":"10.1038\/s41379-022-01100-z_bib20","doi-asserted-by":"crossref","unstructured":"Bishop, J. A., Cowan, M. L., Shum, C. H. & Westra, W. H. MAML2 Rearrangements in Variant Forms of Mucoepidermoid Carcinoma: Ancillary Diagnostic Testing for the Ciliated and Warthin-like Variants. Am. J. Surg. Pathol. 42, 130-136 (2018).","DOI":"10.1097\/PAS.0000000000000932"},{"key":"10.1038\/s41379-022-01100-z_bib21","doi-asserted-by":"crossref","unstructured":"Martins, C., Cavaco, B., Tonon, G., Kaye, F. J., Soares, J. & Fonseca, I. A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands. J. Mol. Diagn.6, 205-210 (2004).","DOI":"10.1016\/S1525-1578(10)60511-9"},{"key":"10.1038\/s41379-022-01100-z_bib22","doi-asserted-by":"crossref","unstructured":"Zhu, F., Wang, W., Hou, Y., Shi, J., Liu, Z., He D., et al. MAML2 Rearrangement in Primary Pulmonary Mucoepidermoid Carcinoma and the Correlation with FLT1 Expression. Plos One9 (2014).","DOI":"10.1371\/journal.pone.0094399"},{"key":"10.1038\/s41379-022-01100-z_bib23","doi-asserted-by":"crossref","unstructured":"Jee, K. J., Persson, M., Heikinheimo, K., Passador-Santos, F., Aro, K., Knuutila, S., et al. Genomic profiles and CRTC1-MAML2 fusion distinguish different subtypes of mucoepidermoid carcinoma. Mod. Pathol.26, 213222 (2013).","DOI":"10.1038\/modpathol.2012.154"},{"key":"10.1038\/s41379-022-01100-z_bib24","doi-asserted-by":"crossref","unstructured":"Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati,A., Petticrew, M., et al. Preferred reporting items for systematic review and metaanalysis protocols (PRISMA-P) 2015 statement. Syst. Rev.4, 1-1 (2015).","DOI":"10.1186\/2046-4053-4-1"},{"key":"10.1038\/s41379-022-01100-z_bib25","unstructured":"Page, M. J., McKenzie, JE., Bossuyt, P. M., Boutron, I., Hoffman, T. C., Mulrow, C. D., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ372, n71 (2021)."},{"key":"10.1038\/s41379-022-01100-z_bib26","doi-asserted-by":"crossref","unstructured":"Moola, S., Munn, Z., Sears, K., Sfetcu, R., Currie, M., Lisy, K. et al. Conducting systematic reviews of association (etiology): The Joanna Briggs Institute's approach. Int. J. Evid. Based Healthc.13, 163169 (2015).","DOI":"10.1097\/XEB.0000000000000064"},{"key":"10.1038\/s41379-022-01100-z_bib27","unstructured":"Moola, S., Munn, Z. T. C., Aromataris, E., Sears, K., Sfetcu, R., Currie, M., et al. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E and Munn Z (ed). Joanna Briggs Institute Reviewer's Manual. (The Joanna Briggs Institute, 2017)."},{"key":"10.1038\/s41379-022-01100-z_bib28","doi-asserted-by":"crossref","unstructured":"Achcar Rde, O., Nikiforova, M. N., Dacic, S., Nicholson, A. G. & Yousem, S. A. Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma. Hum. Pathol.40, 854-860 (2009).","DOI":"10.1016\/j.humpath.2008.11.007"},{"key":"10.1038\/s41379-022-01100-z_bib29","doi-asserted-by":"crossref","unstructured":"Lennerz, J. K., Perry, A., Mills, J. C., Huettner, P. C. & Pfeifer, J. D. Mucoepidermoid carcinoma of the cervix: another tumor with the t(11;19)-associated CRTC1-MAML2 gene fusion. Am. J. Surg. Pathol.33, 835843 (2009).","DOI":"10.1097\/PAS.0b013e318190cf5b"},{"key":"10.1038\/s41379-022-01100-z_bib30","doi-asserted-by":"crossref","unstructured":"Roden, A. C., Erickson-Johnson, M. R., Yi, E. S. & Garcia, J. J. Analysis of MAML2 rearrangement in mucoepidermoid carcinoma of the thymus. Hum. Pathol.44, 2799-2805 (2013).","DOI":"10.1016\/j.humpath.2013.07.031"},{"key":"10.1038\/s41379-022-01100-z_bib31","doi-asserted-by":"crossref","unstructured":"Saeki, K., Ohisho,Y., Matsuda, R., Mochidome, N., Miyasaka, Y., Yamamoto, H., et al. \u201cPancreatic Mucoepidermoid Carcinoma\u201d Is not a Pancreatic Counterpart of CRTC1\/3-MAML2 Fusion Gene-related Mucoepidermoid Carcinoma of the Salivary Gland, and May More Appropriately be Termed Pancreatic Adenosquamous Carcinoma With Mucoepidermoid Carcinoma-like Features. Am. J. Surg. Pathol. 42, 14191428 (2018).","DOI":"10.1097\/PAS.0000000000001135"},{"key":"10.1038\/s41379-022-01100-z_bib32","doi-asserted-by":"crossref","unstructured":"Kass, J. I., Lee, S. C., Abberbock, S., Seethala, R. R. & Duvvuri, U. Adenosquamous carcinoma of the head and neck: Molecular analysis using CRTC-MAML FISH and survival comparison with paired conventional squamous cell carcinoma. Laryngoscope125, E371-E376 (2015).","DOI":"10.1002\/lary.25519"},{"key":"10.1038\/s41379-022-01100-z_bib33","doi-asserted-by":"crossref","unstructured":"Chenevert, J., Barnes, L. E. & Chiosea, S. I. Mucoepidermoid carcinoma: A five-decade journey. Virchows Arch. 458, 133-140 (2011).","DOI":"10.1007\/s00428-011-1040-y"},{"key":"10.1038\/s41379-022-01100-z_bib34","doi-asserted-by":"crossref","unstructured":"O'Neill, I. D. t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma. Oral Oncol. 45, 2-9 (2009).","DOI":"10.1016\/j.oraloncology.2008.03.012"},{"key":"10.1038\/s41379-022-01100-z_bib35","doi-asserted-by":"crossref","unstructured":"Colombino, M., Paliogiannis, P., Cossu, A., Santeufemia, D. A., Sardinian Lung Cancer (CLC) Study Group, Sini, M. C., et al. EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma. BMC Pulm. Med.19, 209 (2019).","DOI":"10.1186\/s12890-019-0964-x"},{"key":"10.1038\/s41379-022-01100-z_bib36","doi-asserted-by":"crossref","unstructured":"Kim, J., Jang, S. J., Choi, C. M. & Ro, J. Y. Correlation of Histologic Subtypes and Molecular Alterations in Pulmonary Adenocarcinoma: Therapeutic and Prognostic Implications. Adv. Anat. Pathol.23, 330-338 (2016).","DOI":"10.1097\/PAP.0000000000000121"},{"key":"10.1038\/s41379-022-01100-z_bib37","doi-asserted-by":"crossref","unstructured":"Rodriguez, E. F., Jones, R., Morris, C. P., Ettinger, D., Chowsilpa, S. & Maleki, Z. et al. Molecular Alterations in Pulmonary Adenocarcinoma of African Americans. Am. J. Clin. Pathol. 152, 237-242 (2019).","DOI":"10.1093\/ajcp\/aqz038"},{"key":"10.1038\/s41379-022-01100-z_bib38","doi-asserted-by":"crossref","unstructured":"L\u00f6hr, M., Kl\u00f6ppel, G., Maisonneuve, P., Lowenfels, A. B. & L\u00fcttges, J. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis. Neoplasia (New York, N.Y.)7, 17-23 (2005).","DOI":"10.1593\/neo.04445"},{"key":"10.1038\/s41379-022-01100-z_bib39","doi-asserted-by":"crossref","unstructured":"Timar, J. & Kashofer, K. Molecular epidemiology and diagnostics of KRAS mutations in human cancer. Cancer Metastasis Rev. 39, 1029-1038 (2020).","DOI":"10.1007\/s10555-020-09915-5"},{"key":"10.1038\/s41379-022-01100-z_bib40","doi-asserted-by":"crossref","unstructured":"Cros, J., Sbidian, E., Hans, S., Roussel, H., Scotte, F., Tartour, E., et al. Expression and mutational status of treatment-relevant targets and key oncogenes in 123 malignant salivary gland tumours. Ann. Oncol. 24, 2624-2629 (2013).","DOI":"10.1093\/annonc\/mdt338"},{"key":"10.1038\/s41379-022-01100-z_bib41","doi-asserted-by":"crossref","unstructured":"Kardon, D. E., Thompson, L. D. R., Przygodzki, R. M. & Heffess, C. S. Adenosquamous Carcinoma Of The Pancreas: A Clinicopathologic Series Of 25 Cases. Mod. Pathol.14, 443-451 (2001).","DOI":"10.1038\/modpathol.3880332"},{"key":"10.1038\/s41379-022-01100-z_bib42","doi-asserted-by":"crossref","unstructured":"Lennerz, J. K., Perry, A., Dehner, L. P., Pfeifer, J. D. & Lind, A. C. CRTC1 rearrangements in the absence of t(11;19) in primary cutaneous mucoepidermoid carcinoma. Br. J. Dermatol. 161, 925-929 (2009).","DOI":"10.1111\/j.1365-2133.2009.09200.x"},{"key":"10.1038\/s41379-022-01100-z_bib43","doi-asserted-by":"crossref","unstructured":"Kang, H., Tan, M., Bishop, J. A., Jones, S., Sausen, M., Ha, P.K., et al. Whole-exome sequencing of salivary gland mucoepidermoid carcinoma. Clin. Cancer Res. 23, 283-288 (2017).","DOI":"10.1158\/1078-0432.CCR-16-0720"},{"key":"10.1038\/s41379-022-01100-z_bib44","doi-asserted-by":"crossref","unstructured":"Jaeschke, R., Guyatt, G. H. & Sackett, D. L. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The EvidenceBased Medicine Working Group. JAMA271, 703-707 (1994).","DOI":"10.1001\/jama.1994.03510330081039"},{"key":"10.1038\/s41379-022-01100-z_bib45","doi-asserted-by":"crossref","unstructured":"Rodger, M., Ramsay, T. & Fergusson, D. Diagnostic randomized controlled trials: the final frontier. Trials13, 137-137 (2012).","DOI":"10.1186\/1745-6215-13-137"},{"key":"10.1038\/s41379-022-01100-z_bib46","doi-asserted-by":"crossref","unstructured":"Lijmer, J. G. & Bossuyt, P. M. Various randomized designs can be used to evaluate medical tests. J. Clin. Epidemiol.62, 364-373 (2009).","DOI":"10.1016\/j.jclinepi.2008.06.017"},{"key":"10.1038\/s41379-022-01100-z_bib47","doi-asserted-by":"crossref","unstructured":"Burns, P. B., Rohrich, R. J. & Chung, K. C. The levels of evidence and their role in evidence-based medicine. Plast. Reconstr. Surg.128, 305-310 (2011).","DOI":"10.1097\/PRS.0b013e318219c171"},{"key":"10.1038\/s41379-022-01100-z_bib48","doi-asserted-by":"crossref","unstructured":"Murad, M. H., Asi, N., Alsawas, M. & Alahdab, F. New evidence pyramid. J. Evid. Based Med. 21, 125 (2016).","DOI":"10.1136\/ebmed-2016-110401"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01100-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01100-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222002642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222002642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01100-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:33:50Z","timestamp":1760229230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222002642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0893395222002642"],"URL":"https:\/\/doi.org\/10.1038\/s41379-022-01100-z","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities?","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-022-01100-z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}]}}